200 related articles for article (PubMed ID: 16143789)
41. A patch source model for treatment planning of ruthenium ophthalmic applicators.
Astrahan MA
Med Phys; 2003 Jun; 30(6):1219-28. PubMed ID: 12852546
[TBL] [Abstract][Full Text] [Related]
42. 103Pd strings: Monte Carlo assessment of a new approach to brachytherapy source design.
Rivard MJ; Reed JL; DeWerd LA
Med Phys; 2014 Jan; 41(1):011716. PubMed ID: 24387508
[TBL] [Abstract][Full Text] [Related]
43. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
[TBL] [Abstract][Full Text] [Related]
44. Monte Carlo dosimetric parameter study of a new (32)P brachytherapy source.
Wu J; Huang J; Long F; Wang C; Wu Z; Gou C
Br J Radiol; 2016 Jun; 89(1062):20150783. PubMed ID: 27042802
[TBL] [Abstract][Full Text] [Related]
45. Potential impact of prostate edema on the dosimetry of permanent seed implants using the new 131Cs (model CS-1) seeds.
Chen Z; Deng J; Roberts K; Nath R
Med Phys; 2006 Apr; 33(4):968-75. PubMed ID: 16696473
[TBL] [Abstract][Full Text] [Related]
46. Calculating prescription doses for new sources by biologically effective dose matching.
Pritz J; Forster KM; Saini AS; Biagioli MC; Zhang GG
Brachytherapy; 2012; 11(6):521-7. PubMed ID: 22436519
[TBL] [Abstract][Full Text] [Related]
47. Some treatment planning considerations for 103Pd and 125I permanent interstitial implants.
Nath R; Meigooni AS; Melillo A
Int J Radiat Oncol Biol Phys; 1992; 22(5):1131-8. PubMed ID: 1555965
[TBL] [Abstract][Full Text] [Related]
48. Calculation of the 3-D dose distribution surrounding a 103Pd stent.
McLemore LB; Horton JL; Antolak JA
Cardiovasc Radiat Med; 2001; 2(3):181-90. PubMed ID: 11786325
[TBL] [Abstract][Full Text] [Related]
49. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
Thomson RM; Taylor RE; Rogers DW
Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
[TBL] [Abstract][Full Text] [Related]
50. Dose perturbation effects in prostate seed implant brachytherapy with I-125.
Mobit P; Badragan I
Phys Med Biol; 2004 Jul; 49(14):3171-8. PubMed ID: 15357190
[TBL] [Abstract][Full Text] [Related]
51. Influence of breast composition and interseed attenuation in dose calculations for post-implant assessment of permanent breast 103Pd seed implant.
Afsharpour H; Pignol JP; Keller B; Carrier JF; Reniers B; Verhaegen F; Beaulieu L
Phys Med Biol; 2010 Aug; 55(16):4547-61. PubMed ID: 20668347
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy.
Dhanesar SK; Lim TY; Du W; Bruno TL; Frank SJ; Kudchadker RJ
J Appl Clin Med Phys; 2015 Sep; 16(5):62–75. PubMed ID: 26699290
[TBL] [Abstract][Full Text] [Related]
53. AAPM TG-43U1 formalism adaptation and monte carlo dosimetry simulations of multiple-radionuclide brachytherapy sources.
Nuttens VE; Lucas S
Med Phys; 2006 Apr; 33(4):1101-7. PubMed ID: 16696487
[TBL] [Abstract][Full Text] [Related]
54. The impact of edema on planning 125I and 103Pd prostate implants.
Yue N; Dicker AP; Nath R; Waterman FM
Med Phys; 1999 May; 26(5):763-7. PubMed ID: 10360539
[TBL] [Abstract][Full Text] [Related]
55. Experimental determination of dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of 103Pd-model Pd-1.
Nath R; Yue N; Roa E
Med Phys; 2002 Oct; 29(10):2433-4. PubMed ID: 12408318
[TBL] [Abstract][Full Text] [Related]
56. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant.
Furstoss C; Reniers B; Bertrand MJ; Poon E; Carrier JF; Keller BM; Pignol JP; Beaulieu L; Verhaegen F
Med Phys; 2009 May; 36(5):1848-58. PubMed ID: 19544804
[TBL] [Abstract][Full Text] [Related]
57. Application of a directional palladium-103 brachytherapy device on a curved surface.
Veltchev I; Price R; Chen X; Howell K; Meyer J; Ma CM
Med Phys; 2019 Apr; 46(4):1905-1913. PubMed ID: 30734318
[TBL] [Abstract][Full Text] [Related]
58. TG-43U1 parameterization of elongated RadioCoil 103Pd brachytherapy sources.
Dini SA; Awan SB; Dou K; Meigooni AS
J Appl Clin Med Phys; 2007 Jul; 8(3):60-75. PubMed ID: 17712301
[TBL] [Abstract][Full Text] [Related]
59. The coupling of anisotropy and radial dose functions for 103Pd and 125I for use with a commercial treatment planning system.
Prete JJ; Bice WS; Dubois DF; Prestidge BR
Med Phys; 1997 Apr; 24(4):523-5. PubMed ID: 9127302
[TBL] [Abstract][Full Text] [Related]
60. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
